February 14 2018 | 0 Comments | 174 reads Average Rating: 3

Poll Results: Predicting the Potential of Predictive & Prescriptive Analytics

by SCIO Health Analytics in Life Sciences

During a recent webinar entitled “Gaining a Competitive Advantage through Predictive and Prescriptive Analytics,” SCIO experts explained how life sciences companies could leverage data analytics to gain a competitive advantage by getting a handle on what could happen in the future.

More specifically, they explained how predictive and prescriptive methodologies could help organizations expand new and current markets, increase patient compliance, enhance direct and indirect messaging to targeted healthcare providers, and develop and monitor the performance of outcomes-based contracts.

During the webinar, attendees also had the opportunity to weigh in with their opinions on the value of prescriptive and predictive analytics. The following was uncovered via opinion polls that were conducted in real time during the online presentation:

According to the poll results, life sciences organizations are already using predictive and prescriptive analytics. In fact, the overwhelming majority of respondents are already using such advanced analytics to bolster marketing and sales effectiveness – while some are using advanced analytics to develop their managed markets and market expansion strategies.

What’s concerning, however, is that even though many life sciences organizations are leaning on analytics, they don’t really feel like they are standing on solid ground. Indeed, almost two-thirds of survey respondents expressed that they are either somewhat or not very confident in the insights drawn from these advanced analytic methodologies.

Confidence in predictive and prescriptive analytics could increase as time marches on and as organizations more fully leverage these methodologies. While many organizations are using prescriptive and predictive analytics, most are still in the very early stages of their use and, therefore, might not yet be taking full advantage.

These poll results offer insights into how life sciences companies are leveraging data analytics to gain a competitive advantage to get a handle on the future. How is your organization leveraging predictive and prescriptive analytics?

Download full infographic | Watch on-demand webinar | View webinar slideshare

Also read:

Pushing the Data Analytics Envelope: From Understanding to Predicting to Taking Action by John Pagliuca and Mark Feeney.

Rate this Article:

Average: 3 (2 votes)

SCIO Health Analytics

Log in to post comments



Arun Rangamani
SVP, Care Optimization and SCIOXpert Services

Ben Steverman
Chief Technology Officer

Bob Abrahamson
Vice President, Product Management

David Hom
Chief Evangelist

Dr. Kevin Keck
Chief Medical Officer

Jen Cressman
Vice President, Professional Services

John Pagliuca
Vice President, Life Sciences

Jonathan Niloff, MD (Guest Author)
President, Niloff Healthcare Strategies, LLC

Lalithya Yerramilli
Vice President, Analytics

Lesli Adams, MPA (Guest Author)
Director of Population Health Strategy, Oracle Corporation

Leslie Strader
Project Manager

Linda Pantovic (Guest Author)
Director of Compliance & Risk Adjustment, Scripps Health Plan Services

Mark Feeney
Life Sciences Consultant

Monique Pierce
Vice President, Business Optimization

Nayfe Faillace
Chief Compliance & Privacy Officer

Nicole Cormier
Senior Manager, Home Health

Priyanka Rajkumar
VP - SCIOXpert and Solutions, Analytics

Rachel Hall
Senior Business Analyst

Rena Bielinski
SVP, Strategic Accounts

Rodger Smith
SVP, Payment Integrity

Rose Higgins
President, North America

Subha Vaidyanathan
VP, Technology and Data Management

Taryn Bevilacqua
Compliance Director

Tom Peterson
SVP, Risk Adjustment


Sign up to receive the latest SCIO news & insights, industry updates, event updates and more, right in your inbox.